Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A New Frontier in Tumor Eradication: Harnessing In Vivo Cellular Reprogramming for Durable Cancer Immunotherapy

Cellular Reprogramming(2024)10.1089/cell.2024.0077Source: DataRank Database

A New Frontier in Tumor Eradication: Harnessing In Vivo Cellular Reprogramming for Durable Cancer Immunotherapy is a research paper published in Cellular Reprogramming (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Constantinos Chronis ORCID

Live enrichment

PubMed:39387283 PMC:PMC12344109 OpenAlex:https://openalex.org/W4403306751

NHLBI NIH HHS

Grant: R01 HL170286

FWCI

0.00

Citation Percentile

0.3%

greenLicense: https://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12344109/pdf/cell.2024.0077.pdf

publisherhttps://www.liebertpub.com/doi/full-xml/10.1089/cell.2024.0077

publisherhttps://www.liebertpub.com/doi/pdf/10.1089/cell.2024.0077

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12344109

Fields of Study

CAR-T cell therapy researchImmunotherapy and Immune ResponsesVirus-based gene therapy researchAnimalsHumansBasic-Leucine Zipper Transcription FactorsCellular ReprogrammingDendritic CellsImmunotherapyInterferon Regulatory FactorsNeoplasmsProto-Oncogene ProteinsTrans-ActivatorsTumor MicroenvironmentInterferon Regulatory Factor-8Proto-Oncogene Protein Spi-1Repressor Proteins

MeSH Terms

Interferon Regulatory Factor-8Proto-Oncogene Protein Spi-1AnimalsDendritic CellsHumansImmunotherapyNeoplasmsProto-Oncogene ProteinsRepressor ProteinsTrans-ActivatorsInterferon Regulatory FactorsBasic-Leucine Zipper Transcription FactorsTumor MicroenvironmentCellular Reprogramming

Keywords

BiologyReprogrammingCancer immunotherapyImmunotherapyCancerIn vivoFrontierCancer researchComputational biologyGeneticsGenePibCdc1In Situ Reprogramming

Sustainable Development Goals

SDG 0: Zero hunger